bpc-157 fda status warning letter compounding FDA Warning Letter Breakdown: Sterility Failures, Subpotent GLP-1 Drugs, and a Compounding Pharmacy Operating I think this sums it

Retatrutide carries an additional layer of complexity: it is still an investigational compound

Complete dosing chart at 10mg/ml (1ml of bacteriostatic water) Notice the problem at the 1.25mg microdose level

the clinical relevance of this finding in humans is unknown, and in UK and EU prescribing information this is noted as a precaution rather than a formal contraindication but individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) should discuss this with their doctor

These include vegetarians, vegans, older adults, and those with stomach problems

It is studied for potential roles in tissue repair, inflammation regulation, and gastrointestinal protection, but remains an investigational compound without approved medical use